GSA Capital Partners’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-2,696
| Closed | -$40K | – | 1586 |
|
2022
Q2 | $40K | Sell |
2,696
-7,800
| -74% | -$116K | 0.01% | 1302 |
|
2022
Q1 | $188K | Sell |
10,496
-1,324
| -11% | -$23.7K | 0.03% | 1186 |
|
2021
Q4 | $284K | Buy |
11,820
+10,816
| +1,077% | +$260K | 0.04% | 971 |
|
2021
Q3 | $20K | Buy |
+1,004
| New | +$20K | ﹤0.01% | 1362 |
|
2021
Q1 | – | Sell |
-12,027
| Closed | -$193K | – | 1180 |
|
2020
Q4 | $193K | Buy |
+12,027
| New | +$193K | 0.03% | 1002 |
|